Allergan says it stands by statements on Valeant
BOSTON Oct 21 (Reuters) - Allergan Inc said on Tuesday that it believes there is no evidence to support Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management's claims that its chief executive officer spearheaded a campaign to spread misinformation about Valeant.
"Allergan stands by its statements regarding the unsustainability of Valeant's business, and we welcome the opportunity for a full hearing on Valeant's business model at the appropriate time," the company said in a statement.
(Reporting by Svea Herbst-Bayliss, Editing by Franklin Paul)
© Thomson Reuters 2017 All rights reserved.